T Stage and Pretreatment Standardized Uptake Values Predict Tumor Recurrence With 5-Fraction SABR in Early-Stage Non-Small Cell Lung Cancer

T Stage and Pretreatment Standardized Uptake Values Predict Tumor Recurrence With 5-Fraction SABR in Early-Stage Non-Small Cell Lung Cancer

Purpose: : Five-fraction stereotactic ablative radiotherapy (SABR) regimens are frequently used to treat centrally located early-stage non-small cell lung cancer or disease in the proximity of the chest wall as a means of optimizing tumor control and reducing treatment toxicity. However, increasing...

Full description

Bibliographic Details
Main Authors: Eric J. Hsu, PhD, Jameson T. Mendel, MD, Kristin A. Ward, MD, Mariam El-Ashmawy, MD, Minjae Lee, PhD, Hak Choy, MD, Kenneth D. Westover, MD, PhD, Dat T. Vo, MD, PhD, Robert D. Timmerman, MD, David J. Sher, MD, Puneeth Iyengar, MD, PhD
Format: Article
Language:English
Published: Elsevier 2022-09-01
Series:Advances in Radiation Oncology
Online Access:http://www.sciencedirect.com/science/article/pii/S2452109422001026

Internet

http://www.sciencedirect.com/science/article/pii/S2452109422001026

Similar Items